Jens‐Otto Andreas

545 total citations
18 papers, 458 citations indexed

About

Jens‐Otto Andreas is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Jens‐Otto Andreas has authored 18 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 4 papers in Oncology. Recurrent topics in Jens‐Otto Andreas's work include Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Jens‐Otto Andreas is often cited by papers focused on Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Jens‐Otto Andreas collaborates with scholars based in Germany, Belgium and United Kingdom. Jens‐Otto Andreas's co-authors include Willi Cawello, Marina Braun, H. P. Zahradnik, Michelle V. Middle, Armel Stockis, Svetlana Dimova, Atef Halabi, Ulrich Jahnel, Klaus Linz and Johannes Schneider and has published in prestigious journals such as Neurology, Annals of the New York Academy of Sciences and European Journal of Pharmacology.

In The Last Decade

Jens‐Otto Andreas

18 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens‐Otto Andreas Germany 11 106 105 104 103 54 18 458
Magdalena Bosak Poland 12 24 0.2× 44 0.4× 187 1.8× 163 1.6× 8 0.1× 40 392
Vaibhav Rastogi United States 11 106 1.0× 28 0.3× 26 0.3× 24 0.2× 62 1.1× 43 433
Ramis Çolak Türkiye 12 16 0.2× 45 0.4× 13 0.1× 37 0.4× 68 1.3× 35 451
Saul Berkovitz United Kingdom 8 22 0.2× 25 0.2× 74 0.7× 10 0.1× 19 0.4× 17 323
Renate Kimmerle Germany 10 27 0.3× 60 0.6× 10 0.1× 71 0.7× 15 0.3× 15 507
Ioannis Lempesis Greece 13 25 0.2× 38 0.4× 22 0.2× 15 0.1× 116 2.1× 39 512
Alan J. Tuchman United States 11 83 0.8× 58 0.6× 50 0.5× 33 0.3× 68 1.3× 22 447
Xiu-Juan Yan China 11 23 0.2× 25 0.2× 15 0.1× 11 0.1× 38 0.7× 24 295

Countries citing papers authored by Jens‐Otto Andreas

Since Specialization
Citations

This map shows the geographic impact of Jens‐Otto Andreas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens‐Otto Andreas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens‐Otto Andreas more than expected).

Fields of papers citing papers by Jens‐Otto Andreas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens‐Otto Andreas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens‐Otto Andreas. The network helps show where Jens‐Otto Andreas may publish in the future.

Co-authorship network of co-authors of Jens‐Otto Andreas

This figure shows the co-authorship network connecting the top 25 collaborators of Jens‐Otto Andreas. A scholar is included among the top collaborators of Jens‐Otto Andreas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens‐Otto Andreas. Jens‐Otto Andreas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cawello, Willi, Marina Braun, & Jens‐Otto Andreas. (2018). Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation. European Journal of Drug Metabolism and Pharmacokinetics. 43(4). 475–481. 7 indexed citations
2.
Schoedel, Kerri A., Jens‐Otto Andreas, Pamela Doty, Klaus Eckhardt, & Edward M. Sellers. (2017). Randomized, Double-Blind, Placebo- and Active Comparator–Controlled Crossover Study Evaluating the Abuse Potential of the Antiepileptic Drug Lacosamide in Healthy Recreational Drug Users. Journal of Clinical Psychopharmacology. 37(6). 675–683. 5 indexed citations
3.
Cawello, Willi, et al.. (2015). Immediate Steady-state Concentrations in Plasma after Oral or Intravenous Lacosamide Loading Dose (P4.263). Neurology. 84(14_supplement). 1 indexed citations
5.
Toublanc, Nathalie, Malcolm Boyce, Robert Chan, et al.. (2014). Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration. European Journal of Drug Metabolism and Pharmacokinetics. 40(4). 461–469. 3 indexed citations
6.
Cawello, Willi, Armel Stockis, Jens‐Otto Andreas, & Svetlana Dimova. (2014). Advances in epilepsy treatment: lacosamide pharmacokinetic profile. Annals of the New York Academy of Sciences. 1329(1). 18–32. 44 indexed citations
7.
Cawello, Willi, et al.. (2013). No influence of the CYP2C19‐selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine. Clinical Pharmacology in Drug Development. 3(3). 187–193. 8 indexed citations
10.
Braun, Marina, et al.. (2009). Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive. British Journal of Clinical Pharmacology. 68(3). 386–394. 7 indexed citations
11.
Braun, Marina, et al.. (2009). Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa. The Journal of Clinical Pharmacology. 49(9). 1047–1055. 17 indexed citations
12.
Schneider, Johannes, et al.. (2005). Differential effects of human ether-a-go-go-related gene (HERG) blocking agents on QT duration variability in conscious dogs. European Journal of Pharmacology. 512(1). 53–60. 37 indexed citations
14.
Winkler, Ulrich, E. Daume, R Sudik, et al.. (1999). A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.. PubMed. 4(3). 145–54. 20 indexed citations
15.
Winkler, Ulrich, et al.. (1999). A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 μg ethinylestradiol and either 2 mg chlormadinone acetate or 150 μg desogestrel. The European Journal of Contraception & Reproductive Health Care. 4(3). 145–154. 8 indexed citations
16.
Winkler, Ulrich, E. Daume, R Sudik, et al.. (1999). A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 μg ethinylestradiol and either 2 mg chlormadinone acetate or 150 μg desogestrel. The European Journal of Contraception & Reproductive Health Care. 4(3). 145–154. 10 indexed citations
17.
Zahradnik, H. P., et al.. (1998). Efficacy and Safety of the New Antiandrogenic Oral Contraceptive Belara®. Contraception. 57(2). 103–109. 41 indexed citations
18.
Stein, Raimund, Johannes Lotz, Jens‐Otto Andreas, et al.. (1998). Long-term metabolic effects in patients with urinary diversion. World Journal of Urology. 16(4). 292–297. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026